Figure 1From: Serum protein acidic and rich in cysteine (SPARC) as a prognostic marker in soft tissue sarcomasKaplan-Meier and log-rank analyses were used to compare survival of all patients segregated by SPARC expression level. Median survival for the “Low SPARC” group is 22.1 months and “High SPARC” group is 4.4 months (Log rank: p = 0.0016).Back to article page